We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Bicycle

News List

Bicycle Therapeutics, Ionic Pharma Enter License & Collaboration Agreement contractpharma
July 14, 2021
Ionis Pharmaceuticals has exercised its option and entered into an exclusive worldwide license and collaboration agreement with Bicycle Therapeutics for tissue-targeted delivery of oligonucleotide therapeutics using Bicycle’s proprietary bicyclic ...
Cancer Research UK to fund Bicycle’s immuno-oncology candidate pharmaceutical-technology
January 09, 2020
Cancer Research UK has agreed to fund exploratory development of Bicycle Therapeutics’ immuno-oncology candidate BT7401.
Bicycle hires clinical leader ahead of IPO-fueled pipeline push fiercebiotech
May 10, 2019
Bicycle Therapeutics has hired clinical and program management leaders to support development of its anticancer candidates. The hires provide Bicycle with clinical trial expertise at a time when it is contending with the resignation of its chief medical o
Bicycle and DDF collaborate on drug development for CNS conditions pharmaceutical-technology
May 09, 2019
UK-headquartered Bicycle Therapeutics and venture capital fund Dementia Discovery Fund (DDF) have entered into a collaboration to use the former’s bicyclic peptide technology to identify new targets and development novel therapeutics for neurodegenerative